Search results

154 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Effective November 25, 2019, caffeine testing (LAB706; Caffeine Level) will be discontinued in the McLendon Clinical Laboratories Special Chemistry Lab due to low volume of requests.
Located in Employee News Online / 2019 / Dec. 5
Effective September 25, 2018, Herbert C. Whinna, MD, PhD will assume the role as Medical Director of Special Coagulation Laboratory in McLendon Clinical Laboratories. Read the full memo for details.
Located in Employee News Online / 2018 / Sept. 20
Effective July 29, 2019, the UNCMC McLendon Clinical Laboratories Special Chemistry Lab will resume in-house testing for the immunosuppressants everolimus and sirolimus.
Located in Employee News Online / 2019 / Aug. 1
Respiratory Virus Season is Here
Please remember to order both Droplet and Contact Precautions when placing an orders for a Respiratory Panel. The Droplet-Contact sign will have a new color this year, Purple, to indicate that when entering these rooms you must wear a surgical mask as well as gown and gloves.
Located in Vital Signs / 2019 / November 7
UNC researchers help create key diagnostic measures for gastrointestinal disorders
UNC School of Medicine faculty members took on critical roles in amending diagnostic criteria questionnaires for functional GI disorders, which affect millions of people worldwide.
Located in Biochemistry and Biophysics News / / 2016 / June
Effective Jan 8, 2018, 25-Hydroxy Vitamin D testing will change from a laboratory developed test using mass spectrometry to a FDA-approved test that uses immunoassay methodology which is certified by the CDC Vitamin D Standardization Certification Program.
Located in Employee News Online / 2018 / Jan. 11
Due to manufacturer discontinuation of reagents currently used for EBV viral load testing, the UNC McLendon Clinical Laboratories will be sending out all plasma EBV viral load testing to Mayo Medical Laboratories beginning July 3. Please see the full memo for details.
Located in Employee News Online / 2018 / July 12
McLendon Labs Numbered Memo: CORE #121 - CK-MB Testing in Acute Coronary Syndromes
Located in Employee News Online / / 2015 / March
Effective March 31, 2019, the methodology and gene content will be updated for Myeloid Mutation Panels at UNC.
Located in Employee News Online / 2019 / March 28
Beginning Sept. 3, UNC Transfusion Medicine Services will begin adding pathogen-reduced (PR) platelets (also known as pathogen-inactivated platelets) as a portion of the platelet inventory for the hospital. Read the full memo for details.
Located in Employee News Online / 2019 / Aug. 22